Why the study?
Does nimodipine augmentation of fluoxetine improve depression outcomes in patients with vascular depression?
Does nimodipine augmentation of fluoxetine improve depression outcomes in patients with vascular depression?
Augmentation of fluoxetine with nimodipine significantly improves treatment outcomes and reduces recurrence rates in patients with vascular depression.
No takes yet. Share an insight, caveat, or question.
Supports nimodipine augmentation of fluoxetine in vascular depression; confirms RCT benefit over monotherapy for remission.
Taragano et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: